Giloy is safe to use: Ministry of Ayush

Prameyanews English

Published By : Prameya News Bureau | October 05, 2021 IST

New Delhi, Oct 5: Ministry of Ayush has recently noticed safety concerns on use of Guduchi (Tinospora cordifolia) that were published in social media and in some scientific journals. This advisory is being issued to confirm that Guduchi (Tinospora cordifolia) is safe to use but some similar looking plants like Tinospora crispa may be harmful. Guduchi is a popularly known herb, familiar as Giloy and is being used in therapeutics since long in AYUSH systems. There are good number of studies published in peer reviewed indexed Journals to substantiate safety and efficacy of Guduchi (Tinospora cordifolia). Its hepato-protective properties are also well established. Guduchi is known for its immense therapeutic applications and the practices are regulated in accordance with various applicable provisions. It is observed that different species of Tinospora are available and only Tinospora cordifolia should be used in therapeutics, whereas similar looking species like Tinospora crispa may manifest adverse effects. Below is the information about these plant species {"id":140516,"width":846,"height":634,"sizeSlug":"full","linkDestination":"none"} Thus, it is reiterated that Guduchi is a safe and effective Ayurveda medicine, however it is advisable to use it in consultation with a qualified, registered Ayush physician. The Ministry of Ayush has a well-established system of Pharmacovigilance (for reporting of suspected adverse drug reactions from Ayush medication), with its network spreading across all over India. If any suspected adverse event occurs after intake of Ayush medicine it may be reported to the nearby Pharmacovigilance centre through an Ayush physician. Further it is advised to take Ayush medicine and treatment under supervision and consultation of a registered Ayush physician only.

News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp

You Might Also Like

More From Related News

Copyright © 2024 - Summa Real Media Private Limited. All Rights Reserved.